查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1789371

眼科溶液市场：按类型、治疗用途、药物类别、防腐剂、类型、剂型、黏度、分销管道、最终用户和地区划分

Eye Drops Market, By Type, By Therapeutic Application, By Drug Class, By Preservative Status, By Type, By Formulation, By Viscosity, By Distribution Channel, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年眼药水市场价值将达到 68.1 亿美元，到 2032 年将达到 92.7 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 4.2%。

分析范围 分析详细信息
基准年 2024 市场规模（2025年） 68.1亿美元
效能数据 2020-2024 预测期 2025-2032
预测期间的复合年增长率（2025-2032年） 4.20% 预计金额（2032年） 92.7亿美元

全球眼药水市场是眼科製药行业的一个重要领域，涵盖了旨在治疗各种眼科疾病和保持最佳眼部健康的广泛治疗和诊断解决方案。

眼药水，又称眼药水，是针对青光眼、干眼症、过敏性结膜炎、细菌和病毒感染疾病、发炎相关疾病等药物的主要传递机制。该市场包括处方药、非处方药、人工泪液、抗组织胺、抗生素、抗发炎药物以及青光眼药物等特殊製剂。

随着人口老化、长时间使用萤幕、环境污染以及生活方式的改变等因素导致眼部疾病的盛行率不断上升，全球对有效眼部护理的需求持续增长。药物输送系统的技术进步、创新的无防腐剂配方以及能够提高患者依从性和治疗效果的缓释性机制的开发，进一步推动了市场的成长轨迹。

市场动态

全球眼药水市场受多种关键因素驱动，这些因素推动了其在国际市场的扩张。随着老龄化老化，青光眼、黄斑部病变、糖尿病视网膜病变等与年龄相关的疾病正影响着全球数百万人。此外，数位设备使用的快速成长导致电脑视觉症候群和干眼症的发生率激增，对润滑和治疗性眼药水的需求也随之激增。

药物输送系统的技术创新，例如无防腐剂配方和缓释性机制，正在改善患者的依从性和治疗效果，进一步推动市场成长。然而，也存在一些重大因素阻碍市场扩张潜力。眼科产品的严格监管要求需要大量的临床试验和核准流程，这导致漫长的开发週期和巨大的资金投入，这对中小型製造商来说可能是一个障碍。

此外，眼药水中某些防腐剂的污染和副作用风险也引发了患者和医护人员的安全疑虑。知名品牌产品的专利到期也加剧了竞争压力，降低了製药公司的利润率。儘管面临这些挑战，眼药水市场仍蕴藏着巨大的成长与创新机会。此外，由于医疗基础设施的改善和眼部健康意识的不断提升，亚太和拉丁美洲的新兴市场也蕴藏着尚未开发的潜力。

本报告的主要特点

  • 本报告对全球眼科溶液市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
  • 它还强调了每个领域的潜在商机，并描述了该市场的一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球眼药水市场的主要企业已根据公司概况、产品系列、主要亮点、财务绩效和策略等参数进行了分析。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
  • 「全球眼药水市场」报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球眼药水市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 分析目标与前提条件

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章：市场动态、法规与趋势分析

  • 市场动态
  • 驱动程式
  • 抑制因素
  • 机会
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 企业合併（M&A）场景
  • 产业趋势

第四章 全球眼科解决方案市场（按类型）（2020-2032）

  • 处方笺眼药水
  • 非处方眼药水

5. 全球眼科解决方案市场依治疗用途划分（2020-2032）

  • 干眼症（DED）管理
  • 过敏性结膜炎的治疗
  • 青光眼和眼高压
  • 治疗眼部感染疾病（细菌、病毒、霉菌）
  • 发炎或术后护理
  • 瞳孔散大或睫状肌麻痹
  • 诊断染料溶液
  • 术后照护（局部麻醉）
  • 葡萄膜炎
  • 其他视网膜疾病

6. 全球眼科解决方案市场（按药品类别划分）（2020-2032 年）

  • 润滑剂和润肤剂
  • 抗组织胺药
  • 肥大细胞稳定剂
  • 皮质类固醇
  • 非类固醇消炎剂（NSAID）
  • 前列腺素类似物
  • β受体阻断剂
  • α-促效剂
  • 碳酸酐酶抑制剂
  • 抗生素
  • 抗病毒药物
  • 抗真菌药物
  • 血管收缩剂
  • 伴随用药

7. 全球眼科解决方案市场（依防腐剂划分）（2020-2032）

  • 含防腐剂的眼药水
  • 不含防腐剂的眼药水

第 8 章 全球眼科解决方案市场（按类型）（2020-2032 年）

  • 品牌
  • 学名药

9. 全球眼科解决方案市场（按剂型划分）（2020-2032 年）

  • 解决方案
  • 暂停
  • 乳剂

第 10 章 全球眼科解决方案市场（按黏度）（2020-2032 年）

  • 低黏度
  • 中等黏度
  • 高黏度

第 11 章 全球眼科解决方案市场按通路划分（2020-2032 年）

  • 医院药房
  • 零售药局
  • 网路药局

第 12 章 全球眼科解决方案市场（按最终用户划分）（2020-2032 年）

  • 医院
  • 眼科诊所
  • 其他（门诊手术中心）

第 13 章 按地区分類的全球眼科解决方案市场（2020-2032 年）

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 欧洲
      • 德国
      • 英国
      • 西班牙
      • 法国
      • 义大利
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 中东
      • 海湾合作委员会国家
      • 以色列
      • 其他中东地区
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第十四章竞争格局

  • Alcon
  • AbbVie Inc（Allergan）
  • Bausch Health Companies Inc
  • Johnson & Johnson Vision
  • Santen Pharmaceutical Co Ltd
  • Pfizer Inc
  • Bayer AG
  • Sun Pharmaceutical Industries Ltd
  • Otsuka Pharmaceutical Co Ltd
  • Rohto Pharmaceutical Co Ltd
  • Thea Pharma Inc
  • Similasan Corporation
  • Akorn Operating Company LLC
  • Prestige Consumer Healthcare Inc
  • Jamjoom Pharmaceuticals

第十五章 分析师建议

  • “命运之轮”
  • 分析师观点
  • Coherent Opportunity Map (COM)

第十六章参考文献与调查方法

  • 参考
  • 分析方法
  • 关于 Coherent Market Insights
简介目录
Product Code: CMI8253

Eye Drops Market is estimated to be valued at USD 6.81 Bn in 2025 and is expected to reach USD 9.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.81 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.20% 2032 Value Projection: USD 9.27 Bn

The global eye drops market represents a critical segment of the ophthalmic pharmaceutical industry, encompassing a diverse range of therapeutic and diagnostic solutions designed to address various ocular conditions and maintain optimal eye health.

Eye drops, also known as ophthalmic solutions, serve as the primary delivery mechanism for medications targeting conditions such as glaucoma, dry eye syndrome, allergic conjunctivitis, bacterial and viral infections, and inflammation-related disorders. The market encompasses prescription medications, over-the-counter solutions, and specialized formulations including artificial tears, antihistamines, antibiotics, anti-inflammatory agents, and glaucoma medications.

With the increasing prevalence of eye-related disorders driven by factors such as aging populations, prolonged screen time, environmental pollutants, and lifestyle changes, the demand for effective ophthalmic treatments continues to escalate globally. The market's growth trajectory is further supported by technological advancements in drug delivery systems, innovative preservative-free formulations, and the development of sustained-release mechanisms that enhance patient compliance and therapeutic efficacy.

Market Dynamics

The global eye drops market is propelled by several key drivers that collectively fuel its expansion across international markets. The primary growth driver stems from the rising prevalence of ocular disorders, particularly age-related conditions such as glaucoma, macular degeneration, and diabetic retinopathy, which affect millions of individuals worldwide as populations continue to age. Additionally, the exponential increase in digital device usage has led to a surge in computer vision syndrome and dry eye conditions, creating substantial demand for lubricating and therapeutic eye drops.

Technological innovations in drug delivery systems, including preservative-free formulations and extended-release mechanisms, enhance patient compliance and treatment outcomes, further driving market growth. However, the market faces significant restraints that challenge its expansion potential. Stringent regulatory requirements for ophthalmic products necessitate extensive clinical trials and approval processes, resulting in lengthy development timelines and substantial financial investments that may deter smaller manufacturers.

Furthermore, the risk of contamination and adverse reactions associated with certain preservatives in eye drops raises safety concerns among patients and healthcare providers. Patent expirations of major branded products also intensify competitive pressures and reduce profit margins for pharmaceutical companies. Despite these challenges, the market presents substantial opportunities for growth and innovation. The expanding geriatric population globally creates a sustained demand for ophthalmic treatments, while emerging markets in Asia Pacific and Latin America offer untapped potential due to improving healthcare infrastructure and rising awareness about eye health.

Key Features of the Study

  • This report provides in-depth analysis of the global eye drops market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global eye drops market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include major pharmaceutical manufacturers, Alcon, AbbVie Inc (Allergan), Bausch Health Companies Inc, Johnson & Johnson Vision, Santen Pharmaceutical Co Ltd, Pfizer Inc, Bayer AG, Sun Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Rohto Pharmaceutical Co Ltd, Thea Pharma Inc, Similasan Corporation, Akorn Operating Company LLC, Prestige Consumer Healthcare Inc, and Jamjoom Pharmaceuticals.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global eye drops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eye drops market

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Prescription Eye Drops
    • Over-the-Counter (OTC) Eye Drops
  • Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Dry Eye Disease (DED) Management
    • Allergic Conjunctivitis Treatment
    • Glaucoma & Ocular Hypertension
    • Eye Infection Treatment (Bacterial, Viral, Fungal)
    • Inflammation or Post-Surgical Care
    • Mydriasis or Cycloplegia
    • Diagnostic Dye Solutions
    • Post-Operative Care (Anesthetic Drops)
    • Uveitis
    • Other Retinal Disorders
  • Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
    • Lubricants and Emollients
    • Antihistamines
    • Mast Cell Stabilizers
    • Corticosteroids
    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Prostaglandin Analogs
    • Beta-Blockers
    • Alpha Agonists
    • Carbonic Anhydrase Inhibitors
    • Antibiotics
    • Antivirals
    • Antifungals
    • Vasoconstrictors
    • Combination Drugs
  • Preservative Status Insights (Revenue, USD Bn, 2020 - 2032)
    • Preserved Eye Drops
    • Preservative-Free Eye Drops
  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Brand
    • Generics
  • Formulation Insights (Revenue, USD Bn, 2020 - 2032)
    • Solution
    • Suspension
    • Emulsion
  • Viscosity Insights (Revenue, USD Bn, 2020 - 2032)
    • Low Viscosity
    • Medium Viscosity
    • High Viscosity
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Ophthalmology Clinics
    • Others (Ambulatory Surgery Centers)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Alcon
    • AbbVie Inc (Allergan)
    • Bausch Health Companies Inc
    • Johnson & Johnson Vision
    • Santen Pharmaceutical Co Ltd
    • Pfizer Inc
    • Bayer AG
    • Sun Pharmaceutical Industries Ltd
    • Otsuka Pharmaceutical Co Ltd
    • Rohto Pharmaceutical Co Ltd
    • Thea Pharma Inc
    • Similasan Corporation
    • Akorn Operating Company LLC
    • Prestige Consumer Healthcare Inc
    • Jamjoom Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Eye Drops Market, By Type
    • Global Eye Drops Market, By Therapeutic Application
    • Global Eye Drops Market, By Drug Class
    • Global Eye Drops Market, By Preservative Status
    • Global Eye Drops Market, By Type
    • Global Eye Drops Market, By Formulation
    • Global Eye Drops Market, By Viscosity
    • Global Eye Drops Market, By Distribution Channel
    • Global Eye Drops Market, By End User
    • Global Eye Drops Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Eye Drops Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prescription Eye Drops
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Over-the-Counter (OTC) Eye Drops
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Eye Drops Market, By Therapeutic Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Dry Eye Disease (DED) Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Allergic Conjunctivitis Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Glaucoma & Ocular Hypertension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Eye Infection Treatment (Bacterial, Viral, Fungal)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Inflammation or Post-Surgical Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mydriasis or Cycloplegia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Dye Solutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Post-Operative Care (Anesthetic Drops)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Uveitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Retinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Eye Drops Market, By Drug Class, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Lubricants and Emollients
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Antihistamines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mast Cell Stabilizers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Prostaglandin Analogs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Beta-Blockers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Alpha Agonists
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Carbonic Anhydrase Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Antivirals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Antifungals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Vasoconstrictors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Combination Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Eye Drops Market, By Preservative Status, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Preserved Eye Drops
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Preservative-Free Eye Drops
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Eye Drops Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Brand
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Generics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Eye Drops Market, By Formulation, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Emulsion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Eye Drops Market, By Viscosity, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Low Viscosity
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Medium Viscosity
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • High Viscosity
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Eye Drops Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Eye Drops Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ophthalmology Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Ambulatory Surgery Centers)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

13. Global Eye Drops Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

14. Competitive Landscape

  • Alcon
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie Inc (Allergan)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bausch Health Companies Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson Vision
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Santen Pharmaceutical Co Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Otsuka Pharmaceutical Co Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Rohto Pharmaceutical Co Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thea Pharma Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Similasan Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Akorn Operating Company LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Prestige Consumer Healthcare Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Jamjoom Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

15. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

16. References and Research Methodology

  • References
  • Research Methodology
  • About us